Verisk (VRSK): Adjusted EPS Rose 5.3% — But Profits Actually Fell 1.9%. Is 28x Justified?

Verisk Analytics (VRSK) Q2 2026 — Verisk Analytics (VRSK) — the data monopoly behind the forms, rules and loss costs US property & casualty insurers write policies from — reported Q2 2026 (quarter ended June 30) before the open on July 29. Revenue was $806.3M (+4.3%, +5.8% organic constant currency), a slight beat; adjusted EPS $1.98 beat the $1.93 expected; FY26 guidance was reaffirmed. But GAAP net income FELL 9.8% to $228.6M — and the number nobody reported is that adjusted net income was $259.3M vs $264.4M, DOWN 1.9%. The 5.3% adjusted-EPS growth is entirely a 6.8% smaller share count. Our owner-earnings DCF lands at ~$180 vs the $213.15 July 29 close. Our call: HOLD, 3/5. Verisk owns one of the widest moats in the market — its ISO forms, rules and loss costs are filed with state regulators and wired into nearly every US property & casualty carrier's workflow, which is why ~84% of revenue is prepaid, auto-renewing subscriptions. Q2 2026 looked like a clean beat until you read the reconciliation: adjusted net income fell 1.9%, GAAP EBITDA fell 2.0%, and GAAP EBITDA margin dropped 350 basis points to 54.2% — masked by adding back $18.7M of fees from the collapsed $2.35B AccuLynx acquisition, which the FTC ran out the clock on and which went to trial in Delaware Chancery June 23-26 with damages Verisk says are not estimable. Growth is price: the 10-Q says Underwriting grew 'primarily due to an annual increase in prices,' and with subscriptions +8.0% against 5.8% total organic growth, the ~16% transactional book is shrinking. The buyback was funded with leverage — cash fell from $2,178M to $551M, net debt rose $1.36B to $3.92B, interest expense is up 48.7%, and shareholders' equity is now a DEFICIT of $1.19B. Credit where due: stock comp is under 2% of revenue and is NOT added back to adjusted EBITDA. Our owner-earnings DCF (~$1,164M owner earnings, 9.0% discount rate, 6.5% growth fading to 4.5%, 2.5% terminal) lands at ~$180 versus the $213.15 close; the reverse DCF says today's price requires ~8% growth a year for a decade. THE CALL: HOLD (3/5, A GREAT BUSINESS AT A PRICE THAT ALREADY ASSUMES THE RE-ACCELERATION — WATCH ADJUSTED NET INCOME, NOT ADJUSTED EPS) — base-case value ~$180.00 vs ~$213.15 today. What to watch: transactional revenue stops shrinking, second-half organic growth prints inside the company's own 6-8% range, and adjusted NET INCOME — not just adjusted EPS — starts growing again. The risks: an adverse Delaware Chancery ruling in the AccuLynx case with damages Verisk says cannot be estimated, another year of price-only growth on a consolidating P&C customer base, or net leverage pushing past 2.5x to fund more buybacks Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.